Even though the XRCC2 A variant allele of rs3218536 has been shown by cell complementation assays to somewhat augment sensitivity to damage [32], there are no published studies which suggest a relationship between patients with the variant allele of rs3218550 and breast cancer. Here, XRCC2 is linked to breast cancer.